Selected Publications
Fortunato MP, Girard A, Coratti S, Farraday D, Norton L, Rareshide C, Zhu J, Chokshi N, Szymczak JE, Klaiman T, Russell LB, Small DS, Patel MS, Volpp KGM, Fanaroff AC.: Investigating racial and gender disparities in virtual randomized clinical trial enrollment: Insights from the BE ACTIVE study Am Heart J 276 : 120-124,2024.
Schneider DJ, McMahon SR, Angiolillo, DJ, Fanaroff A, Ibrahim H, Hohl PK, Wanamaker BL, Effron MB, DiBattiste PM: Platelet FcgRIIa as a Marker of Cardiovascular Risk After Myocardial Infarction
J Am Coll Cardiol 84 (18): 1721-1729,2024.
Berwanger O, Wojdyla DM, Fanaroff AC, Budaj A, Granger CB, Mehran R, Aronson R, Windecker S, Goodman SG, Alexander JH, Lopes RD.: Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS J Am Coll Cardiol 84 : 875-885,2024.
Volpp KG, Mahraj K, Norton LA, Asch DA, Glanz K, Mehta SJ, Balasta M, Kellum W, Wood J, Russell LB, Fanaroff AC, Bakshi S, Jacoby D, Cohen JB, Press MJ, Clark K, Zhu J, Rareside C, Ashcraft LE, Snider C, Putt ME.: Design and Rationale of Penn Medicine Healthy Heart, a Randomized Trial of Effectiveness of a Centrally Organized Approach to Blood Pressure and Cholesterol Improvement Among Patients at Elevated Risk of Atherosclerotic Cardiovascular Disease Am Heart J. : 2024.
Fanaroff AC, Huang Q, Clark K, Norton LA, Kellum WE, Eichelberger D, Wood JC, Bricker Z, Wood AGD, Kemmer G, Smith JI, Adusumalli S, Putt M, Volpp KGM.: Two randomized controlled trials of nudges to encourage referrals to centralized pharmacy services for evidence-based statin initiation in high-risk patients: Rationale and design of the SUPER LIPID program Am Heart J 273 : 83-89,2024.
Fanaroff AC, Hirshfeld Jr JW: Chronic Coronary Disease Med Clin North Am 108 (3): xvii-xx,2024.
Fanaroff AC, Patel MS, Chokshi N, Coratti S, Farraday D, Norton L, Rareshide C, Zhu J, Klaiman T, Szymczak JE, Russell LB, Small DS, Volpp KGM.: Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial Circulation 149 : 1639-1649,2024.
Fanaroff AC, Dayoub EJ, Yang L, Schultz K, Ramadan OI, Wang GJ, Damrauer SM, Genovese EA, Secemsky EA, Parikh SA, Nathan AS, Kohi MP, Weinberg MD, Jaff MR, Groeneveld PW, Giri JS.: Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort J Am Heart Assoc 13 : e033898,2024.
Fanaroff AC, Dayoub EJ, Yang L, Schultz K, Ramadan OI, Wang GJ, Damrauer SM, Genovese EA, Secemsky EA, Parikh SA, Nathan AS, Kohi MP, Weinberg MD, Jaff MR, Groeneveld PW, Giri JS.: Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort J Am Heart Assoc. 13 (9): e033898,2024.
Patel PP, Fanaroff AC: Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy Med Clin North Am 108 (3): 489-507,2024.
Academic Contact Information
Perelman Center for Advanced Medicine
11-103 South PCAM
Philadelphia,
PA
19104
Phone: 215-615-7674
Patient appointments: 800-789-7366